169 related articles for article (PubMed ID: 9688341)
1. Genetic association of Ctla-4 to myasthenia gravis with thymoma.
Huang D; Liu L; Norén K; Xia SQ; Trifunovic J; Pirskanen R; Lefvert AK
J Neuroimmunol; 1998 Aug; 88(1-2):192-8. PubMed ID: 9688341
[TBL] [Abstract][Full Text] [Related]
2. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis.
Wang XB; Kakoulidou M; Qiu Q; Giscombe R; Huang D; Pirskanen R; Lefvert AK
Genes Immun; 2002 Feb; 3(1):46-9. PubMed ID: 11857062
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism].
Mao HT; Wang XB; Zhang L; Gu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):574-8. PubMed ID: 15583985
[TBL] [Abstract][Full Text] [Related]
4. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis.
Huang D; Giscombe R; Zhou Y; Pirskanen R; Lefvert AK
J Neuroimmunol; 2000 Jun; 105(1):69-77. PubMed ID: 10713366
[TBL] [Abstract][Full Text] [Related]
5. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.
Chuang WY; Ströbel P; Gold R; Nix W; Schalke B; Kiefer R; Opitz A; Klinker E; Müller-Hermelink HK; Marx A
Ann Neurol; 2005 Oct; 58(4):644-8. PubMed ID: 16178018
[TBL] [Abstract][Full Text] [Related]
6. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers.
Pascuzzi RM; Sermas A; Phillips LH; Johns TR
Neurology; 1986 Mar; 36(3):423-7. PubMed ID: 3951715
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence.
Wang XB; Kakoulidou M; Giscombe R; Qiu Q; Huang D; Pirskanen R; Lefvert AK
J Neuroimmunol; 2002 Sep; 130(1-2):224-32. PubMed ID: 12225905
[TBL] [Abstract][Full Text] [Related]
8. The role of thymomas in the development of myasthenia gravis.
Marx A; Müller-Hermelink HK; Ströbel P
Ann N Y Acad Sci; 2003 Sep; 998():223-36. PubMed ID: 14592880
[TBL] [Abstract][Full Text] [Related]
9. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis.
Fernández-Mestre MT; Vargas V; Montagnani S; Cotúa M; Ogando V; Layrisse Z
Hum Immunol; 2004 Jan; 65(1):54-9. PubMed ID: 14700596
[TBL] [Abstract][Full Text] [Related]
10. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
[TBL] [Abstract][Full Text] [Related]
11. The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis.
Chuang WY; Ströbel P; Belharazem D; Rieckmann P; Toyka KV; Nix W; Schalke B; Gold R; Kiefer R; Klinker E; Opitz A; Inoue M; Kuo TT; Müller-Hermelink HK; Marx A
Genes Immun; 2009 Dec; 10(8):667-72. PubMed ID: 19693092
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
Nithiyananthan R; Heward JM; Allahabadia A; Franklyn JA; Gough SC
Thyroid; 2002 Jan; 12(1):3-6. PubMed ID: 11842815
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?
Kristiansen OP; Larsen ZM; Pociot F
Genes Immun; 2000 Feb; 1(3):170-84. PubMed ID: 11196709
[TBL] [Abstract][Full Text] [Related]
14. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.
Vaidya B; Imrie H; Perros P; Young ET; Kelly WF; Carr D; Large DM; Toft AD; McCarthy MI; Kendall-Taylor P; Pearce SH
Hum Mol Genet; 1999 Jul; 8(7):1195-9. PubMed ID: 10369864
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.
Ligers A; Teleshova N; Masterman T; Huang WX; Hillert J
Genes Immun; 2001 May; 2(3):145-52. PubMed ID: 11426323
[TBL] [Abstract][Full Text] [Related]
16. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis.
Huang D; Giscombe R; Zhou Y; Lefvert AK
J Rheumatol; 2000 Feb; 27(2):397-401. PubMed ID: 10685804
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.
Fukazawa T; Yanagawa T; Kikuchi S; Yabe I; Sasaki H; Hamada T; Miyasaka K; Gomi K; Tashiro K
J Neurol Sci; 1999 Dec; 171(1):49-55. PubMed ID: 10567049
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
20. Polygenic disease associations in thymomatous myasthenia gravis.
Amdahl C; Alseth EH; Gilhus NE; Nakkestad HL; Skeie GO
Arch Neurol; 2007 Dec; 64(12):1729-33. PubMed ID: 18071035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
